The Stop Aids Campaign welcomes the engagement of GlaxoSmithKline's chief executive, Andrew Witty, with the proposal to establish a medicines patent pool...We encourage Witty to go further and fully endorse patent pools not only for research, but for existing, patented HIV treatments such as the Unitaid patent pool (Katy Athersuch, Coordinator, Stop Aids Campaign)